Search Ontology:
ChEBI

beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc

Term ID
CHEBI:71344
Synonyms
  • 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-deoxy-alpha-D-galactopyranose
  • 2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranose
  • 2-acetamido-3-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-alpha-D-galactopyranose
  • alpha-D-galactopyranose, 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-deoxy-
  • beta-D-GlcNAc-(1->3)-alpha-D-GalNAc
  • GlcNAcb1-3GalNAca
  • GlcNAcbeta1-3GalNAcalpha
  • N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D-galactosamine
Definition
An amino disaccharide comprising an N-acetyl-β-D-glucosamine residue linked (1→3) to an N-acetyl-β-D-galactosamine residue at the reducing end.
References
  • glygen:G00035MO
  • glytoucan:G00035MO
  • pubmed:19443021
  • pubmed:25568069
  • pubmed:31537530
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc
Phenotype where environments contain beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc
Phenotype modified by environments containing beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc
Phenotype affecting beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc
Human Disease Model